The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp.

International Journal of Antimicrobial Agents

Volumn 24, Issue 5, 2004, Pages 428-432

  Escribano, Isabel ^a   Rodríguez, Juan Carlos ^a   Cebrian, Laura ^a   Royo, Gloria ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

Active efflux systems; Quinolone; Salmonella

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; NALIDIXIC ACID; OFLOXACIN; PHENYLALANYLARGININE 2 NAPHTHYLAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; RESERPINE; SPARFLOXACIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG SCREENING; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; SALMONELLA;

BIOLOGICAL TRANSPORT; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; QUINOLONES; SALMONELLA;

EID: 7044232125     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.05.004     Document Type: Article

References (32)

1. Cherubin C.E., Eng R.H. Quinolones for the treatment of infections due to Salmonella. Rev. Infect. Dis. 13:1991;343-344
2. Seral C., Lopez L., Castillo F.J., Clavel A., Rubio M.C. Resistencia a quinolonas en Salmonella enterica. Rev. Esp. Quimioter. 11:1998;43-46
3. Ruiz M., Sirvent E., Hernández C., Rodríguez J.C., Royo G. Evolución de las resistencias de las quinolonas en Salmonella enterica en nuestro medio. Rev. Esp. Quimioter. 12:1999;366-368
4. Heurtin Le Corre C., Donnio P.Y., Perrin M., Travert M.F., Avril J.L. Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. enterica serotype Typhimurium isolates from humans and animals. J. Clin. Microbiol. 37:1999;266-269
5. Stock I., Wiedemann B. Natural antibiotic susceptibility of Salmonella enterica strains. Int. J. Antimicrob. Agents. 16:2000;211-217
6. Witte W. Ecological impact of antibiotic use in animals on different complex microflora: environment. Int. J. Antimicrob. Agents. 14:2000;321-325
7. Moreno M.A., Domínguez L., Teshager T., Herrero I.A., Porrero M.C. Antibiotic resistance monitoring: the Spanish programme. The VAV network. Red de vigilancia de resistencias antibióticas en bacterias de origen veterinario. Int. J. Antimicrob. Agents. 14:2000;285-290
8. Martel J.L., Tardy F., Brisabois A., Lailler R., Coudert M., Chaslus-Dancla E. The French antibiotic resistance monitoring programs. Int. J. Antimicrob. Agents. 14:2000;275-283
9. Vila J., Ruiz J., Navia M.M. Molecular basis of quinolone resistance acquisition in Gram-negative bacteria. Recent Res. Devel. Antimicrob. Agents Chemother. 3:1999;323-344
10. Piddock L.J.V. Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol. Rev. 26:2002;3-16
11. Ribera A., Ruiz J., Jimenez de Anta M.T., Vila J. Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates. J. Antimicrob. Chemother. 49:2002;697-702
12. Ribera A., Jurado A., Ruiz J., Marco F. In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine. Diagn. Microbiol. Infect. Dis. 42:2002;123-128
13. Nikaido H. Multidrug efflux pumps of Gram-negative bacteria. J. Bacteriol. 178:1996;5853-5859
14. Poole K. Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrob. Agents Chemother. 44:2000;2233-2241
15. Randall L.P., Cooles S.W., Sayers A.R., Woodward M.J. Association between cyclohexane resistance in Salmonella of different serovars and increased resistance to multiple antibiotics. J. Med. Microbiol. 50:2001;919-924
16. Nikaido H., Basina M., Nguyen V., Rosenberg E.Y. Multidrug efflux pump AcrAB of Salmonella Typhimurium excretes only those betalactam antibiotics containing lipophilic side chain. J. Bacteriol. 180:1998;4686-4692
17. Baucheron S., Imberechts H., Chaslus-Dancla E., Cloeckaert A. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb. Drug Resist. 8:2002;281-289
18. Schmitz F.J., Fluit A.C., Luckefahr M., Engler B., Hofmann B., Verhoef J., et al. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 42:1998;807-810
19. Markham P.N., Neyfakh A.A. Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1996;2673-2674
20. Piddock L.J.V., Johnson M.M., Simjee S., Pumbwe L. Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:2002;808-812
21. Miyamae S., Nikaido H., Tanaka Y., Yoshimura F. Active efflux of norfloxacin by Bacteroides fragilis. Antimicrob. Agents Chemother. 42:1998;2119-2121
22. Raherison S., Gonzalez P., Rena din H., Chadron A. Evidence of active efflux in resistance to ciprofloxacin and to anthodium bromide by Mycoplasma hominis. Antimicrob. Agents Chemother. 46:2002;672-679
23. Lomovskaya O., Warren M.S., Lee A., Galazzo J., Fronko R., Lee M., et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:2001;105-116
24. Mazzariol A, Tokue Y, Kanegawa TM, Cornaglia G, Nikaido H. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother 2000;44:3441-3.
25. Allen K.J., Poppe C. Phenotypic and genotypic characterization of food animal isolates of Salmonella with reduced sensitivity to ciprofloxacin. Microb. Drug Resist. 8:2002;375-383
26. Tejedor M.T., Martin J.L., Navia M., Freixes J., Vila J. Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections. Vet. Microbiol. 94:2003;295-301
27. Kaatz G.W., Seo S.M., Rubie C.A. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 37:1993;1086-1094
28. Kaatz G.W., Seo S.M. Inducible norA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1995;2650-2655
29. Medders W.M., Wooley R.E., Gibbs P.S., Shotts E.B., Brown J. Mutation rate of avian intestinal coliform bacteria when pressured with fluoroquinolones. Avian Dis. 42:1998;146-153
30. Pers C., Sogaard P., Pallesen L. Selection of multiple resistances in Salmonella enteritidis during treatment with ciprofloxacin. Scand. J. Infect. Dis. 28:1996;529-531
31. Aarestrup F.M., Wiuff C., Molbak K., Threlfall E.J. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob. Agents Chemother. 47:2003;827-829
32. Giraud E., Cloeckaert A., Kerboeuf D., Chaslus-Dancla E. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 44:2000;1223-1228